Drug Trial Radar · NCT05403866
A Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug Product in AIS Subjects
Last checked: Nov 19, 2026Latest source record: Dec 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
89
Actual
Start
Aug 17, 2022
Primary completion
May 23, 2025
Study completion May 23, 2025
Sponsor
- Lead sponsor
- Lumosa Therapeutics Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jun 3, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase II, double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy of multiple doses of LT3001 drug product in subjects with acute ischemic stroke (AIS)
Conditions
- Acute Ischemic Stroke
Interventions
LT3001 Drug ProductDrug
Administered by intravenous infusion
PlaceboDrug
Administered by intravenous infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Proportion of Subjects With Adverse Events (AEs), Judged to be Probably or Definitely Related to the Investigational Product (IP), Within 90 Days After the First IP Administration.Time frame: within 90 days after the first IP administration
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Chattanooga Center for Neurologic Research
Chattanooga, Tennessee
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.